VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 27 filers reported holding VASCULAR BIOGENICS LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $96,000 | -40.7% | 80,295 | -32.9% | 0.03% | -69.0% |
| Q3 2019 | $162,000 | -47.9% | 119,681 | -50.0% | 0.09% | -77.7% |
| Q2 2019 | $311,000 | -37.6% | 239,188 | -27.0% | 0.39% | +63.6% |
| Q1 2019 | $498,000 | -78.4% | 327,504 | -86.2% | 0.24% | -52.8% |
| Q4 2018 | $2,302,000 | -33.4% | 2,373,203 | +11.6% | 0.51% | +14.5% |
| Q3 2018 | $3,454,000 | -15.4% | 2,125,738 | +14.5% | 0.44% | -30.0% |
| Q2 2018 | $4,084,000 | – | 1,856,169 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
| Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
| DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
| PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
| Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
| Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
| HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
| MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
| Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |